The global orexin receptor market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Orexins are also known as hypocretins. They are two neuropeptides secreted from orexin-containing neurons, mainly in the lateral hypothalamus (LH). They play a vital regulatory role in many physiological processes such as feeding behavior, sleep–wake rhythm, reward and addiction and energy balance. The major factor driving the growth of the market is the rising prevalence of depressive disorder across the globe.
Get Free Sample link @ https://www.omrglobal.com/request-sample/orexin-receptor-market
According to the National Institute of Mental Health (NHIM), in 2019, an estimated 19.4 million adults in the US had at least one major depressive episode which represented 7.8% of adults. Furthermore, according to World Health Organization (WHO), depression is a leading cause of disability globally with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years in 2021. Hence, the increasing prevalence of the depressive disorder is driving the demand for orexin receptors owing to their application as an anti-depressant which in turn is driving the growth of the market.
Some major players in the market include Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Eisai Co., Ltd. announced the launch of its in-house-discovered and developed orexin receptor antagonist DAYVIGO 2.5 mg, 5 mg, 10 mg tablets (lemborexant) in Japan. It is used for the treatment of insomnia.
Full report of Orexin Receptor Market available @ https://www.omrglobal.com/industry-reports/orexin-receptor-market
Market Coverage
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Orexin Receptor Market Report by Segment
By Type
- Orexin 1 Receptor
- Orexin 2 Receptor
By Application
- Insomnia
- Sleep Disorders
- Major Depressive Disorder
- Other
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/orexin-receptor-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
